Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family

Abstract

Approximately 10% of all breast cancer (BC) cases are familial and caused by inheritance of mutant BRCA1, BRCA2, or some other genes from the same DNA reparation pathway. Genetic counseling in families with cancer history is a powerful means for early cancer detection and active risk reduction through preventive interventions. This is the first report of the rare inherited BRCA2 frameshift-deletion mutation c.3847_3848delGT in one Lithuanian pedigree with the intense familial history of BC. Three BRCA2-positive blood relatives with BC of different biological types were identified in this pedigree with the same type mutation. All three cases were diagnosed with advanced stage ductal carcinoma. Markedly, polymorphic cells and numerous mitoses were identified in BC from the cases. Two patients from the family were diagnosed with the triple negative tumors, while one case had early onset of the hormone positive BC. Despite the variation in clinical and biological presentation of BC, all cases showed a good response to conventional treatment. In conclusion, the strong influence of BRCA2 mutation on the onset of BC of various biological types reveals the complexity of genetic counselling in families with BC history.

The effect of silencing the Tip60 gene on the response to radiotherapy in breast cancer cells

“…The fact that patients in the TNBC group "poorly differentiated, common in those over 50 years of age and associated with BRCA1 gene polymorphism, which corresponds to approximately 10% of invasive BC", do not respond to hormone therapy, and the combination of chemotherapy and radiotherapy may be a problem in individuals with highly active DNA repair pathways [ 4 ]. Radiotherapy to breast cancer patients is applied at almost every stage to reduce the risk of recurrence after the surgery and to alleviate the symptoms caused by cancer that has metastasized to other parts of the body.…”